It was an isolated but exemplary action that should be emulated by doctors, hospitals, medical societies, and disease research charities. The leadership of these organizations can pressure drug companies to deliver value and reduce prices; after all, if doctors don’t prescribe treatments they consider overpriced, there is no market.
